Proton Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition (CPPD) in a Population-Based Study

Oct-18

AUTHORS : Dr Tuhina Neogi, Department of Rheumatology, Boston University School of Medicine, Boston, MA 2118, USA – Email: tneogi@bu.edu – Profile: https://www.bumc.bu.edu/busm/profile/tuhina-neogi/

JOURNAL : Arthritis & Rheumatology

REFERENCE: 70(S9): 2456-57

DOI : 10.1002/art.40700

Proton Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition (CPPD) in a Population-Based Study

More publications

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Increased risk of fracture among patients with iron overload: a population-based matched cohort study